Garenoxacin Mesylate hydrate

  Cat. No.:  DC8893  
Chemical Structure
223652-90-2
For research use only. We do not sell to patients.
We match the best price and quality on market.
Email:order@dcchemicals.com  sales@dcchemicals.com
Tel:+86-021-58447131
We are official vendor of:
  • 20
  • 19
  • 18
  • 17
  • 16
  • 15
  • 14
  • 12
  • 11
  • 10
  • 9
  • 8
  • 13
  • 6
  • 5
  • 4
  • 3
  • 2
  • 1
More than 5000 active chemicals with high quality for research!
Field of application
Garenoxacin mesylate hydrate is a novel oral des-fluoro(6) quinolone with potent antimicrobial activity, against common respiratory pathogens, including resistant strains.
Cas No.: 223652-90-2
SMILES: O.CS(=O)(O)=O.FC(OC1=C(C2C=CC3[C@H](NCC=3C=2)C)C=CC2=C1N(C1CC1)C=C(C2=O)C(=O)O)F
Formula: C24H26F2N2O8S
M.Wt: 540.53
Purity: >98%
Sotrage: 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO
MSDS
COA
LOT NO. DOWNLOAD
2018-0101
Cat. No. Product name Field of application
DC8115 Vancomycin hydrochloride Vancomycin hydrochloride in stock,price: 500 USD/100mg. 0
DC7940 TBA-354 TBA-354 is a potent anti-tuberculosis compound; maintains activity against Mycobacterium tuberculosis H37Rv isogenic monoresistant strains and clinical drug-sensitive and drug-resistant isolates.
DCAPI1325 Rifabutin (Mycobutin) Rifabutin (Mycobutin)
DC4148 Retapamulin Retapamulin is a topical antibiotic, which binds to both E. coli and S. aureus ribosomes with similar potencies with Kd of 3 nM.
DC8893 Garenoxacin Mesylate hydrate Garenoxacin mesylate hydrate is a novel oral des-fluoro(6) quinolone with potent antimicrobial activity, against common respiratory pathogens, including resistant strains.
DC8929 Garenoxacin Garenoxacin is a quinolone antibiotic for the treatment of Gram-positive and Gram-negative bacterial infections.
DC10307 Framycetin Framycetin (Fradiomycin B; Neomycin B) is an aminoglycoside antibiotic. It inhibits hammerhead ribozyme with a Ki of 13.5 μM.
DC8937 Clarithromycin Clarithromycin is a macrolide antibiotic and a CYP3A4 inhibitor.
X